About: Vincent Launay-Vacher

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Vincent Launay-Vacher Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) researcher (en) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) ഗവേഷകൻ (ml) araştırmacı (tr) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq)
rdfs:label	Vincent Launay-Vacher (en) Vincent Launay-Vacher (es) Vincent Launay-Vacher (nl) Vincent Launay-Vacher (sl) Vincent Launay-Vacher (ast)
skos:prefLabel	Vincent Launay-Vacher (en) Vincent Launay-Vacher (es) Vincent Launay-Vacher (nl) Vincent Launay-Vacher (sl) Vincent Launay-Vacher (ast)
name	Vincent Launay-Vacher (en) Vincent Launay-Vacher (es) Vincent Launay-Vacher (nl) Vincent Launay-Vacher (sl) Vincent Launay-Vacher (ast)
given name	wds:Q46647654-6B0484F4-B585-4E99-8090-A6E31B63100E
given name	Vincent
instance of	wds:Q46647654-D8F404F9-A8E1-4BAA-B219-FF610CADF99C
instance of	Homo sapiens
occupation	wds:Q46647654-1E4EF60A-BCE5-4E5A-8AE7-B85FFC8728A2
employer	wds:Q46647654-AE199516-1ED5-483C-9AE6-624981BF617C wds:Q46647654-E406B6DE-E1BE-4AB4-BEDD-87AF9BF92612
NUKAT ID	wds:Q46647654-75B23F56-4AEF-47D4-9C2F-7B4E84A1A62A
sex or gender	wds:Q46647654-5DDEABE7-1C60-4C0C-ACE0-15FEF191BD2A
ISNI	wds:Q46647654-8E8748BF-749B-4C9E-A65D-2C0176D2FC83
VIAF ID	wds:Q46647654-C81BEC10-C39F-4E2D-949B-3C62DCCC21D6
IdRef ID	wds:Q46647654-62BB726A-BCE2-499B-B0DE-E33A4EAF61FE
date of birth	wds:Q46647654-CD7437D0-1BE1-402F-AD17-D5F86C57FAA1
educated at	wds:Q46647654-1AB61C7B-31F3-4446-B24D-0A5564B4E29A
WorldCat Identities ID (superseded)	wds:Q46647654-439E0859-ABB4-4A1A-BDEF-23C56FDEB1F9
National Library of Spain ID	wds:Q46647654-1D565095-5A00-45BC-A449-3B5DA1F3A1BE
VIAF ID	http://viaf.org/viaf/66745235
IdRef ID	http://www.idref.fr/071364978/id
National Library of Spain ID	http://datos.bne.es/resource/XX5435772
occupation	researcher
employer	Laboratoires Pierre Fabre Pfizer (France)
NUKAT ID	n2016181555
sex or gender	male
ISNI	0000000002487722
VIAF ID	66745235
IdRef ID	071364978
date of birth	1972-01-01 00:00:00Z (xsd:dateTime)
educated at	Paris Descartes University
WorldCat Identities ID (superseded)	viaf-66745235
National Library of Spain ID	XX5435772
ORCID iD	wds:Q46647654-CDC564BE-6C02-4C9C-A1D0-C5873697F769
ORCID iD	https://orcid.org/0000-0002-5717-1703
ORCID iD	0000-0002-5717-1703
ResearcherID	wds:Q46647654-0D17F51A-6051-4EA2-9590-682417511B2A
Publons author ID	wds:Q46647654-c8bf8c80-a453-4128-ae91-4f66acb6657c
ResearcherID	C-1826-2013
Publons author ID	406129
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q46647654
is author of	Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile? Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study Risk of cancer in patients following chronic dialysis and kidney graft New therapies for hepatitis C: considerations in patients with renal impairment. Pharmacokinetics of abacavir in HIV-1-infected patients with impaired renal function Antiretroviral and immunosuppressive drug-drug interactions: an update Antiviral drug-induced nephrotoxicity Viral load and HIV-associated nephropathy Ear and kidney syndromes: molecular versus clinical approach Cancer and renal insufficiency results of the BIRMA study. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study Lung cancer and renal insufficiency: prevalence and anticancer drug issues. Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA study group Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care Gemcitabine-induced thrombotic microangiopathy: a systematic review Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant]. Pharmacokinetics of nelfinavir in an HIV patient with renal insufficiency Renal Tubular Drug Transporters Medication misuse in hospitalized patients with renal impairment Topiramate-induced renal tubular acidosis Doxycycline, gastrointestinal bleeding, and thrombotic microangiopathy Drug-induced Fanconi's syndrome. An appraisal of antiretroviral drugs in hemodialysis.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software